Cargando…

Resting Energy Expenditure and Body Composition in Children and Adolescents With Genetic, Hypothalamic, Medication-Induced or Multifactorial Severe Obesity

BACKGROUND: Pediatric obesity is a multifactorial disease which can be caused by underlying medical disorders arising from disruptions in the hypothalamic leptin-melanocortin pathway, which regulates satiety and energy expenditure. AIM: To investigate and compare resting energy expenditure (REE) and...

Descripción completa

Detalles Bibliográficos
Autores principales: Abawi, Ozair, Koster, Emma C., Welling, Mila S., Boeters, Sanne C.M., van Rossum, Elisabeth F. C., van Haelst, Mieke M., van der Voorn, Bibian, de Groot, Cornelis J., van den Akker, Erica L. T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9309560/
https://www.ncbi.nlm.nih.gov/pubmed/35898454
http://dx.doi.org/10.3389/fendo.2022.862817
_version_ 1784753193127772160
author Abawi, Ozair
Koster, Emma C.
Welling, Mila S.
Boeters, Sanne C.M.
van Rossum, Elisabeth F. C.
van Haelst, Mieke M.
van der Voorn, Bibian
de Groot, Cornelis J.
van den Akker, Erica L. T.
author_facet Abawi, Ozair
Koster, Emma C.
Welling, Mila S.
Boeters, Sanne C.M.
van Rossum, Elisabeth F. C.
van Haelst, Mieke M.
van der Voorn, Bibian
de Groot, Cornelis J.
van den Akker, Erica L. T.
author_sort Abawi, Ozair
collection PubMed
description BACKGROUND: Pediatric obesity is a multifactorial disease which can be caused by underlying medical disorders arising from disruptions in the hypothalamic leptin-melanocortin pathway, which regulates satiety and energy expenditure. AIM: To investigate and compare resting energy expenditure (REE) and body composition characteristics of children and adolescents with severe obesity with or without underlying medical causes. METHODS: This prospective observational study included pediatric patients who underwent an extensive diagnostic workup in our academic centre that evaluated endocrine, non-syndromic and syndromic genetic, hypothalamic, and medication-induced causes of obesity. REE was assessed by indirect calorimetry; body composition by air displacement plethysmography. The ratio between measured REE (mREE) and predicted REE (Schofield equations), REE%, was calculated, with decreased mREE defined as REE% ≤90% and elevated mREE ≥110%. Additionally, the influence of fat-free-mass (FFM) on mREE was evaluated using multiple linear regression. RESULTS: We included 292 patients (146 [50%] with body composition measurements), of which 218 (75%) patients had multifactorial obesity and 74 (25%) an underlying medical cause: non-syndromic and syndromic genetic (n= 29 and 28, respectively), hypothalamic (n= 10), and medication-induced (n= 7) obesity. Mean age was 10.8 ± 4.3 years, 59% were female, mean BMI SDS was 3.8 ± 1.1, indicating severe obesity. Mean REE% was higher in children with non-syndromic genetic obesity (107.4% ± 12.7) and lower in children with hypothalamic obesity (87.6% ± 14.2) compared to multifactorial obesity (100.5% ± 12.6, both p<0.01). In 9 children with pseudohypoparathyroidism type 1a, mean REE% was similar (100.4 ± 5.1). Across all patients, mREE was decreased in 60 (21%) patients and elevated in 69 (24%) patients. After adjustment for FFM, mREE did not differ between patients within each of the subgroups of underlying medical causes compared to multifactorial obesity (all p>0.05). CONCLUSIONS: In this cohort of children with severe obesity due to various etiologies, large inter-individual differences in mREE were found. Consistent with previous studies, almost half of patients had decreased or elevated mREE. This knowledge is important for patient-tailored treatment, e.g. personalized dietary and physical activity interventions and consideration of pharmacotherapy affecting central energy expenditure regulation in children with decreased mREE.
format Online
Article
Text
id pubmed-9309560
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-93095602022-07-26 Resting Energy Expenditure and Body Composition in Children and Adolescents With Genetic, Hypothalamic, Medication-Induced or Multifactorial Severe Obesity Abawi, Ozair Koster, Emma C. Welling, Mila S. Boeters, Sanne C.M. van Rossum, Elisabeth F. C. van Haelst, Mieke M. van der Voorn, Bibian de Groot, Cornelis J. van den Akker, Erica L. T. Front Endocrinol (Lausanne) Endocrinology BACKGROUND: Pediatric obesity is a multifactorial disease which can be caused by underlying medical disorders arising from disruptions in the hypothalamic leptin-melanocortin pathway, which regulates satiety and energy expenditure. AIM: To investigate and compare resting energy expenditure (REE) and body composition characteristics of children and adolescents with severe obesity with or without underlying medical causes. METHODS: This prospective observational study included pediatric patients who underwent an extensive diagnostic workup in our academic centre that evaluated endocrine, non-syndromic and syndromic genetic, hypothalamic, and medication-induced causes of obesity. REE was assessed by indirect calorimetry; body composition by air displacement plethysmography. The ratio between measured REE (mREE) and predicted REE (Schofield equations), REE%, was calculated, with decreased mREE defined as REE% ≤90% and elevated mREE ≥110%. Additionally, the influence of fat-free-mass (FFM) on mREE was evaluated using multiple linear regression. RESULTS: We included 292 patients (146 [50%] with body composition measurements), of which 218 (75%) patients had multifactorial obesity and 74 (25%) an underlying medical cause: non-syndromic and syndromic genetic (n= 29 and 28, respectively), hypothalamic (n= 10), and medication-induced (n= 7) obesity. Mean age was 10.8 ± 4.3 years, 59% were female, mean BMI SDS was 3.8 ± 1.1, indicating severe obesity. Mean REE% was higher in children with non-syndromic genetic obesity (107.4% ± 12.7) and lower in children with hypothalamic obesity (87.6% ± 14.2) compared to multifactorial obesity (100.5% ± 12.6, both p<0.01). In 9 children with pseudohypoparathyroidism type 1a, mean REE% was similar (100.4 ± 5.1). Across all patients, mREE was decreased in 60 (21%) patients and elevated in 69 (24%) patients. After adjustment for FFM, mREE did not differ between patients within each of the subgroups of underlying medical causes compared to multifactorial obesity (all p>0.05). CONCLUSIONS: In this cohort of children with severe obesity due to various etiologies, large inter-individual differences in mREE were found. Consistent with previous studies, almost half of patients had decreased or elevated mREE. This knowledge is important for patient-tailored treatment, e.g. personalized dietary and physical activity interventions and consideration of pharmacotherapy affecting central energy expenditure regulation in children with decreased mREE. Frontiers Media S.A. 2022-07-11 /pmc/articles/PMC9309560/ /pubmed/35898454 http://dx.doi.org/10.3389/fendo.2022.862817 Text en Copyright © 2022 Abawi, Koster, Welling, Boeters, van Rossum, van Haelst, van der Voorn, de Groot and van den Akker https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Endocrinology
Abawi, Ozair
Koster, Emma C.
Welling, Mila S.
Boeters, Sanne C.M.
van Rossum, Elisabeth F. C.
van Haelst, Mieke M.
van der Voorn, Bibian
de Groot, Cornelis J.
van den Akker, Erica L. T.
Resting Energy Expenditure and Body Composition in Children and Adolescents With Genetic, Hypothalamic, Medication-Induced or Multifactorial Severe Obesity
title Resting Energy Expenditure and Body Composition in Children and Adolescents With Genetic, Hypothalamic, Medication-Induced or Multifactorial Severe Obesity
title_full Resting Energy Expenditure and Body Composition in Children and Adolescents With Genetic, Hypothalamic, Medication-Induced or Multifactorial Severe Obesity
title_fullStr Resting Energy Expenditure and Body Composition in Children and Adolescents With Genetic, Hypothalamic, Medication-Induced or Multifactorial Severe Obesity
title_full_unstemmed Resting Energy Expenditure and Body Composition in Children and Adolescents With Genetic, Hypothalamic, Medication-Induced or Multifactorial Severe Obesity
title_short Resting Energy Expenditure and Body Composition in Children and Adolescents With Genetic, Hypothalamic, Medication-Induced or Multifactorial Severe Obesity
title_sort resting energy expenditure and body composition in children and adolescents with genetic, hypothalamic, medication-induced or multifactorial severe obesity
topic Endocrinology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9309560/
https://www.ncbi.nlm.nih.gov/pubmed/35898454
http://dx.doi.org/10.3389/fendo.2022.862817
work_keys_str_mv AT abawiozair restingenergyexpenditureandbodycompositioninchildrenandadolescentswithgenetichypothalamicmedicationinducedormultifactorialsevereobesity
AT kosteremmac restingenergyexpenditureandbodycompositioninchildrenandadolescentswithgenetichypothalamicmedicationinducedormultifactorialsevereobesity
AT wellingmilas restingenergyexpenditureandbodycompositioninchildrenandadolescentswithgenetichypothalamicmedicationinducedormultifactorialsevereobesity
AT boeterssannecm restingenergyexpenditureandbodycompositioninchildrenandadolescentswithgenetichypothalamicmedicationinducedormultifactorialsevereobesity
AT vanrossumelisabethfc restingenergyexpenditureandbodycompositioninchildrenandadolescentswithgenetichypothalamicmedicationinducedormultifactorialsevereobesity
AT vanhaelstmiekem restingenergyexpenditureandbodycompositioninchildrenandadolescentswithgenetichypothalamicmedicationinducedormultifactorialsevereobesity
AT vandervoornbibian restingenergyexpenditureandbodycompositioninchildrenandadolescentswithgenetichypothalamicmedicationinducedormultifactorialsevereobesity
AT degrootcornelisj restingenergyexpenditureandbodycompositioninchildrenandadolescentswithgenetichypothalamicmedicationinducedormultifactorialsevereobesity
AT vandenakkerericalt restingenergyexpenditureandbodycompositioninchildrenandadolescentswithgenetichypothalamicmedicationinducedormultifactorialsevereobesity